Fundraising FoxPrimaltherapies
1 known investors
Find your way into Primaltherapies
Sign up to see every warm intro you have to Primaltherapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Primaltherapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Primal Therapies develops microbial biotechnology, including patented small molecule drugs and functional ingredients for biofilm management, infection control, and microbiome modulation. Its SMMRT platform targets metabolic receptors and enzymes in bacteria, viruses, and fungi to address antimicrobial resistance, disinfection, and chronic disease across healthcare and other industries.
Investors · 1
Frequently asked questions
- What does Primaltherapies do?
- Primal Therapies develops microbial biotechnology, including patented small molecule drugs and functional ingredients for biofilm management, infection control, and microbiome modulation. Its SMMRT platform targets metabolic receptors and enzymes in bacteria, viruses, and fungi to address antimicrobial resistance, disinfection, and chronic disease across healthcare and other industries.
- Who are Primaltherapies's investors?
- Primaltherapies's investors include P5 Health Ventures.